Marcos III Perez

Enterprise Strategy & Metrics: Direct global medical affairs strategy, establishing impact frameworks and analytics to drive data-driven decision-making and omnichannel engagement. Operations & Governance: Oversee cross-functional medical communication, strategic project execution, and global budget allocation to maximize operational efficiency.

Portfolio Strategy: Spearheaded global medical team across 5 core therapeutic areas (Gastroenterology, Allergy, Cough & Cold, Nutritionals, Pain) Cross-TA Governance: Represented Medical Affairs on Transversal Governance Committees and chaired Cross-Therapeutic Area Innovation Platforms to accelerate pipeline development.

Brand Strategy & Leadership: Designed and executed the global medical strategy for Enterogermina and Probiotics portfolio Evidence Generation: Principal Medical Lead for 4 global Phase 3 trials and 2 RWE studies in Gastroenterology, driving product claim expansions and 20+ peer-reviewed publications. KOL & Scientific Engagement: Chaired global scientific advisory boards with key opinion leaders and medical societies, leading omnichannel medical strategies across Europe, LATAM, and Asia.

Dual-Franchise Leadership: Managed combined Country Medical Affairs operations, leading medical strategy, and physician education across General Medicines Established Products (Cardiovascular, Gastroenterology, Diabetes) and Consumer Healthcare portfolios. Organization Building: Built and operationalized the standalone country Consumer Healthcare medical function from the ground up, establishing local medical governance and compliance.

Pharmacovigilance & Safety: Managed a team of safety physicians leading signal detection and post-marketing surveillance across OTC, Medical Device, and Cosmetic portfolios. Regulatory Compliance: Served as lead medical authority for Health Authority inspections and global internal quality audits.